The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rao, A. M., & Hatcher, J. F. (2007) · Brain Research · doi:10.1016/j.brainres.2006.11.080 · Cited by 64
RetractedPROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
THE COLORIMETRIC DETERMINATION OF PHOSPHORUS
Fiske, C. H., & Subbarow, Y. (1925) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)84756-1 · Cited by 18,997
[49] Determination of carbonyl content in oxidatively modified proteins
Levine, R. L., Garland, D., Oliver, C. N., Amici, A., Climent, I., Lenz, A.-G., Ahn, B.-W., Shaltiel, S., & Stadtman, E. R. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86141-h · Cited by 5,887
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Jollow, D. J., Mitchell, J. R., Zampaglione, N., & Gillette, J. R. (2008) · Pharmacology · doi:10.1159/000136485 · Cited by 3,285
Biology of disease: free radicals and tissue injury.
Freeman, B. Α., & Jd, C. (1982) · PubMed · Cited by 3,038
Handbook of methods for oxygen radical research
Greenwald, R. A. (1987) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(87)80012-6 · Cited by 2,381
Free radicals, antioxidants, and human disease: where are we now?
Halliwell, B. B., Gutteridge, J. M. C., & Cross, C. E. (1992) · PubMed · Cited by 2,163
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Purification and characterization of the flavoenzyme glutathione reductase from rat liver.
Carlberg, I., & Mannervik, B. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41206-4 · Cited by 2,020
Biological effects of resveratrol
Frémont, L. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00410-5 · Cited by 1,663
CRC handbook of methods for oxygen radical research
Bogomolets, B. B. (1985) · Experimental Gerontology · doi:10.1016/0531-5565(85)90021-x · Cited by 1,546
Blum, D., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A.-L., Sadoul, R., & Verna, J.-M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246
Glutathione: Toxicological Implications
Reed, D. J. (1990) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.30.040190.003131 · Cited by 759
Modeling Parkinson's Disease in Rats: An Evaluation of 6-OHDA Lesions of the Nigrostriatal Pathway
Deumens, R., Blokland, A., & Prickaerts, J. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7891 · Cited by 758
Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides
Marambaud, P., Zhao, H., & Davies, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508246200 · Cited by 749
Differential distribution of glutathione and glutathione-related enzymes in rabbit kidney
Mohandas, J., Marshall, J. J., Duggin, G. G., Horvath, J. S., & Tiller, D. J. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90353-8 · Cited by 736
Kirik, D., Rosenblad, C., & Björklund, A. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6848 · Cited by 663
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
Teismann, P., Tieu, K., Choi, D.-K., Wu, D.-C., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0837397100 · Cited by 660
Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease
Chen, H., Zhang, S. M., Hernán, M. A., Schwarzschild, M. A., Willett, W. C., Colditz, G. A., Speizer, F. E., & Ascherio, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1059 · Cited by 634
Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer.
Mohandas, J., Marshall, J. J., Duggin, G. G., HORVATH, J. S., & TILLER, D. J. (1984) · PubMed · Cited by 543
Przedbroski, S., Leviver, M., Jiang, H., Ferreira, M., Jackson-Lewis, V., Donaldson, D., & Togasaki, D. M. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00066-r · Cited by 453
Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats
Jin, F., Wu, Q., Lu, Y.-F., Gong, Q.-H., & Shi, J.-S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.005 · Cited by 384
Hudson, J. L., van Horne, C. G., Strömberg, I., Brock, S., Clayton, J., Masserano, J., Hoffer, B. J., & Gerhardt, G. A. (1993) · Brain Research · doi:10.1016/0006-8993(93)90576-9 · Cited by 377
Stevens, M. J., Obrosova, I., Cao, X., Van Huysen, C., & Greene, D. A. (2000) · Diabetes · doi:10.2337/diabetes.49.6.1006 · Cited by 366
Sharma, M., & Gupta, Y. K. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02083-0 · Cited by 326
Murias, M., Handler, N., Erker, T., Pleban, K., Ecker, G., Saiko, P., Szekeres, T., & Jäger, W. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.08.008 · Cited by 288
Prostaglandin D2 formation and characterization of its synthetases in various tissues of adult rats
Ujihara, M., Urade, Y., Eguchi, N., Hayashi, H., Ikai, K., & Hayaishi, O. (1988) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(88)90477-8 · Cited by 256
Chang, J.-W., Wachtel, S. R., Young, D., & Kang, U.-J. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00217-6 · Cited by 248
Ishrat, T., Hoda, M. N., Khan, M. B., Yousuf, S., Ahmad, M., Khan, M. M., Ahmad, A., & Islam, F. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.02.002 · Cited by 230
Self-citationYousuf, S., Atif, F., Ahmad, M., Hoda, N., Ishrat, T., Khan, B., & Islam, F. (2009) · Brain Research · doi:10.1016/j.brainres.2008.10.068 · Cited by 225
Self-citationThe overall rod performance test in the MPTP-treated-mouse model of Parkinsonism
Rozas, G., López-Martı́n, E., Guerra, M. J., & Labandeira-Garcı́a, J. L. (1998) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(98)00078-8 · Cited by 225
Guo, S., Yan, J., Yang, T., Yang, X., Bezard, E., & Zhao, B. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.020 · Cited by 221
Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease
Wahner, A. D., Bronstein, J. M., Bordelon, Y. M., & Ritz, B. (2007) · Neurology · doi:10.1212/01.wnl.0000279519.99344.ad · Cited by 213
Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults
Okawara, M., Katsuki, H., Kurimoto, E., Shibata, H., Kume, T., & Akaike, A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.11.003 · Cited by 200
Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity
Chao, J., Yu, M.-S., Ho, Y.-S., Wang, M., & Chang, R. C.-C. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.07.002 · Cited by 185
Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice
Blanchet, J., Longpré, F., Bureau, G., Morissette, M., DiPaolo, T., Bronchti, G., & Martinoli, M.-G. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.03.024 · Cited by 177
Kumar, P., Padi, S. S., Naidu, P. S., & Kumar, A. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00014 · Cited by 167
Zafar, K. S., Siddiqui, A., Sayeed, I., Ahmad, M., Salim, S., & Islam, F. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01531.x · Cited by 159
Self-citationAhmad, M., Saleem, S., Ahmad, A. S., Yousuf, S., Ansari, M. A., Khan, M. B., Ishrat, T., Chaturvedi, R. K., Agrawal, A. K., & Islam, F. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03000.x · Cited by 152
Self-citationTsai, S.-K., Hung, L., Fu, Y.-T., Cheng, H., Nien, M.-W., Liu, H.-Y., Zhang, F. B.-Y., & Huang, S.-S. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2007.04.044 · Cited by 145
Andrabi, S. A., Spina, M. G., Lorenz, P., Ebmeyer, U., Wolf, G. L., & Horn, T. F. W. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.038 · Cited by 139
Imam, S. Z., & Ali, S. F. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02249-0 · Cited by 138
Chaturvedi, R. K., Shukla, S., Seth, K., Chauhan, S., Sinha, C., Shukla, Y., & Agrawal, A. K. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.008 · Cited by 123
Roghani, M., & Behzadi, G. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03296-0 · Cited by 118
Function of COX-2 and Prostaglandins in Neurological Disease
Liang, X., Wu, L., Wang, Q., Hand, T. A., Bilak, M. M., McCullough, L. B., & Andreasson, K. I. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-0058-8 · Cited by 118
Svoboda, P., & Mosinger, B. J. (1981) · Biochemical Pharmacology · doi:10.1016/0006-2952(81)90626-2 · Cited by 115
Hu, X., Wachtel, S. R., Galloway, M., & White, F. J. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-07-02318.1990 · Cited by 112
Hoozemans, J. J. M., Veerhuis, R., Janssen, I., van Elk, E.-J., Rozemüller, A. J. M., & Eikelenboom, P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03164-5 · Cited by 107
Phillis, J. W., & O’Regan, M. H. (2003) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v15.i1.30 · Cited by 102
Kim, D. K., Rordorf, G. A., Nemenoff, R. A., Koroshetz, W. J., & Bonventre, J. V. (1995) · Biochemical Journal · doi:10.1042/bj3100083 · Cited by 97
Bing, G., Zhang, Y., Watanabe, Y., McEwen, B. S., & Stone, E. A. (1994) · Brain Research · doi:10.1016/0006-8993(94)90534-7 · Cited by 96
Schwarting, R. K. W., Bonatz, A. E., Carey, R. J., & Huston, J. P. (1991) · Brain Research · doi:10.1016/0006-8993(91)90170-z · Cited by 92
Yokoyama, H., Kuroiwa, H., Yano, R., & Araki, T. (2008) · Neurological Sciences · doi:10.1007/s10072-008-0986-2 · Cited by 87
Islam, F., Zia, S., Sayeed, I., Zafar, K. S., & Ahmad, A. S. (2002) · Biological Trace Element Research · doi:10.1385/bter:90:1-3:203 · Cited by 75
Self-citationResveratrol inhibits tumor cell adhesion to endothelial cells by blocking ICAM-1 expression.
Park, J. S., Kim, K. M., Kim, M. H., Chang, H. J., Baek, M. K., Kim, S., & Jung, Y. D. (2009) · PubMed · Cited by 55
García, E., Limon, D., de la Cruz, V. P., Giòrdano, M., Díaz‐Muñoz, M., Maldonado, P. D., Herrera‐Mundo, M. N., Pedraza‐Chaverrí, J., & Santamaría, A. (2008) · Free Radical Research · doi:10.1080/10715760802506356 · Cited by 54
Hoda, M. N., Singh, I., Singh, A. K., & Khan, M. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-21 · Cited by 49
Self-citationProtective effect of resveratrol against lipopolysaccharide-induced oxidative stress in rat brain
Sebaï, H., Gadacha, W., Sani, M., Aouani, E., Ghanem‐Boughanmi, N., & Ben‐Attia, M. (2009) · Brain Injury · doi:10.3109/02699050903379370 · Cited by 40
Warraich, S. T., Allbutt, H. N., Billing, R., Radford, J., Coster, M. J., Kassiou, M., & Henderson, J. M. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.08.023 · Cited by 18
Agrawal, A. K., Husain, R., Raghubir, R., Kumar, A., & Seth, P. K. (1995) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(95)00002-x · Cited by 16
İldan, F., Polat, S., G�cer, A. I., ner, A., İşbir, T., Mete, U., Kaya, M., & Karadayi, A. (1996) · Acta Neurochirurgica · doi:10.1007/bf01411746 · Cited by 13
Cited by
Autophagy and apoptosis dysfunction in neurodegenerative disorders
Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S. R., Jangamreddy, J. R., Mehrpour, M., Christoffersson, J., Chaabane, W., Moghadam, A. R., Kashani, H. H., et al. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.10.004 · Cited by 1,039
Schapira, A. H. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61305-6 · Cited by 494
Nutraceutical Antioxidants as Novel Neuroprotective Agents
Kelsey, N. A., Wilkins, H. M., & Linseman, D. A. (2010) · Molecules · doi:10.3390/molecules15117792 · Cited by 480
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
Vang, O., Ahmad, N., Baile, C. A., Baur, J. A., Brown, K., Csiszar, A., Das, D. K., Delmas, D., Gottfried, C., Lin, H.-Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019881 · Cited by 437
Polyphenols: Multipotent Therapeutic Agents in Neurodegenerative Diseases
Bhullar, K. S., & Rupasinghe, H. P. V. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/891748 · Cited by 411
Metadata
- Authors
- Khan, M. M., Ahmad, A., Ishrat, T., Khan, M. B., Hoda, M. N., Khuwaja, G., Raza, S. S., Khan, A., Javed, H., Vaibhav, K., & Islam, F.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 1328
- Pages
- 139-151
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W1991715802
- Cited by
- 279
- References
- 64
- FWCI
- 9.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.